First Time Loading...

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 14 700 JPY 0.93% Market Closed
Updated: May 6, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

900.1B
+4%
Revenue
Growth Rates:
1 Year
+14%
3 Years
+24%
5 Years
+54%
7 Years
+88%
10 Years
+157%
30.6B
+1%
Operating Income
Growth Rates:
1 Year
+1%
3 Years
-14%
5 Years
+23%
7 Years
+43%
10 Years
+84%
24.1B
+1%
Net Income
Growth Rates:
1 Year
+4%
3 Years
-6%
5 Years
+28%
7 Years
+61%
10 Years
+141%

Earnings Waterfall
Cosmos Pharmaceutical Corp

Revenue
900.1B JPY
Cost of Revenue
-721.7B JPY
Gross Profit
178.4B JPY
Operating Expenses
-147.9B JPY
Operating Income
30.6B JPY
Other Expenses
-6.5B JPY
Net Income
24.1B JPY

Income Statement
Cosmos Pharmaceutical Corp

Rotate your device to view
Income Statement
Currency: JPY
Nov-2013 Feb-2014 May-2014 Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023
Revenue
Revenue
349 966
N/A
360 162
+3%
371 825
+3%
382 823
+3%
392 527
+3%
402 690
+3%
408 466
+1%
414 046
+1%
423 817
+2%
433 328
+2%
447 273
+3%
463 517
+4%
477 739
+3%
490 037
+3%
502 732
+3%
514 880
+2%
526 523
+2%
542 936
+3%
557 999
+3%
572 807
+3%
585 536
+2%
597 715
+2%
611 137
+2%
622 103
+2%
638 034
+3%
653 527
+2%
684 403
+5%
709 064
+4%
723 309
+2%
733 223
+1%
726 424
-1%
726 672
+0%
733 387
+1%
743 612
+1%
755 414
+2%
772 127
+2%
788 292
+2%
802 831
+2%
827 697
+3%
863 228
+4%
900 111
+4%
Gross Profit
Cost of Revenue
(282 835)
(290 754)
(301 268)
(311 438)
(319 477)
(327 815)
(330 391)
(333 599)
(341 614)
(348 821)
(360 420)
(372 666)
(383 589)
(392 372)
(402 688)
(412 577)
(422 626)
(436 534)
(447 681)
(459 531)
(468 775)
(478 364)
(489 353)
(497 933)
(511 642)
(523 343)
(549 419)
(568 888)
(579 286)
(587 636)
(581 313)
(581 810)
(587 706)
(595 877)
(603 966)
(616 375)
(627 825)
(638 527)
(658 979)
(689 790)
(721 674)
Gross Profit
67 131
N/A
69 408
+3%
70 557
+2%
71 385
+1%
73 050
+2%
74 875
+2%
78 075
+4%
80 447
+3%
82 203
+2%
84 507
+3%
86 853
+3%
90 851
+5%
94 150
+4%
97 665
+4%
100 044
+2%
102 303
+2%
103 897
+2%
106 402
+2%
110 318
+4%
113 276
+3%
116 761
+3%
119 351
+2%
121 784
+2%
124 170
+2%
126 392
+2%
130 184
+3%
134 984
+4%
140 176
+4%
144 023
+3%
145 587
+1%
145 111
0%
144 862
0%
145 681
+1%
147 735
+1%
151 448
+3%
155 752
+3%
160 467
+3%
164 304
+2%
168 718
+3%
173 438
+3%
178 437
+3%
Operating Income
Operating Expenses
(50 487)
(52 166)
(53 850)
(55 563)
(57 140)
(59 424)
(60 995)
(62 734)
(64 602)
(66 123)
(68 205)
(70 399)
(72 773)
(75 065)
(77 807)
(80 607)
(83 248)
(85 761)
(87 569)
(89 790)
(91 977)
(94 355)
(97 009)
(99 367)
(101 979)
(104 000)
(105 890)
(107 450)
(108 602)
(109 917)
(111 964)
(113 814)
(115 847)
(118 701)
(121 652)
(125 612)
(130 265)
(134 238)
(138 590)
(143 220)
(147 858)
Selling, General & Administrative
(50 487)
(52 165)
(48 517)
(55 562)
(57 138)
(59 423)
(54 095)
(62 731)
(64 600)
(66 121)
(59 442)
(70 399)
(72 773)
(75 065)
(68 097)
(80 607)
(83 247)
(85 759)
(76 680)
(89 789)
(91 976)
(94 355)
(85 050)
(99 366)
(101 978)
(103 999)
(93 347)
(107 450)
(108 601)
(109 916)
(99 163)
(113 814)
(115 848)
(118 702)
(107 756)
(125 612)
(130 264)
(134 238)
(122 807)
(143 218)
(147 856)
Depreciation & Amortization
0
0
(5 332)
0
0
0
(6 898)
0
0
0
(8 763)
0
0
0
(9 709)
0
0
0
(10 888)
0
0
0
(11 958)
0
0
0
(12 543)
0
0
0
(12 801)
0
0
0
(13 895)
0
0
0
(15 782)
0
0
Other Operating Expenses
0
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(2)
0
0
0
0
0
(1)
0
0
(2)
(1)
(1)
(1)
0
(1)
(1)
0
(1)
0
0
(1)
0
0
0
0
1
(1)
0
(1)
0
(1)
(2)
(2)
Operating Income
16 644
N/A
17 242
+4%
16 707
-3%
15 822
-5%
15 910
+1%
15 451
-3%
17 080
+11%
17 713
+4%
17 601
-1%
18 384
+4%
18 648
+1%
20 452
+10%
21 377
+5%
22 600
+6%
22 237
-2%
21 696
-2%
20 649
-5%
20 641
0%
22 749
+10%
23 486
+3%
24 784
+6%
24 996
+1%
24 775
-1%
24 803
+0%
24 413
-2%
26 184
+7%
29 094
+11%
32 726
+12%
35 421
+8%
35 670
+1%
33 147
-7%
31 048
-6%
29 834
-4%
29 034
-3%
29 796
+3%
30 140
+1%
30 202
+0%
30 066
0%
30 128
+0%
30 218
+0%
30 579
+1%
Pre-Tax Income
Interest Income Expense
50
48
47
45
43
43
38
34
25
9
0
(11)
(15)
(12)
(13)
(13)
(11)
(10)
(10)
(9)
(7)
(7)
(5)
(4)
(5)
(5)
(4)
(3)
(4)
(4)
(3)
(3)
(2)
(1)
0
0
2
3
(4)
(11)
(18)
Non-Reccuring Items
(169)
(171)
223
206
267
859
392
526
501
297
(195)
(164)
667
535
1 146
998
142
(85)
(87)
(431)
(232)
(197)
(154)
110
(92)
(160)
(1 161)
(1 295)
(1 322)
(1 299)
(1 429)
(1 280)
(1 227)
(1 054)
(78)
(34)
(89)
(270)
(313)
(332)
(310)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4 190
0
265
265
265
0
0
0
0
0
0
Total Other Income
1 231
1 357
1 439
1 515
1 542
1 875
1 910
2 074
2 158
1 942
2 043
2 029
2 197
2 279
2 367
2 477
2 499
2 500
2 515
2 472
2 386
2 302
2 523
2 473
2 497
2 629
2 473
2 529
2 583
6 744
2 691
7 061
7 141
3 044
3 065
3 310
3 061
3 084
2 962
2 953
2 971
Pre-Tax Income
17 756
N/A
18 476
+4%
18 416
0%
17 588
-4%
17 762
+1%
18 228
+3%
19 420
+7%
20 347
+5%
20 285
0%
20 632
+2%
20 496
-1%
22 306
+9%
24 226
+9%
25 402
+5%
25 737
+1%
25 158
-2%
23 279
-7%
23 046
-1%
25 167
+9%
25 518
+1%
26 931
+6%
27 094
+1%
27 139
+0%
27 382
+1%
26 813
-2%
28 648
+7%
30 402
+6%
33 957
+12%
36 678
+8%
41 111
+12%
38 596
-6%
36 826
-5%
36 011
-2%
31 288
-13%
33 048
+6%
33 416
+1%
33 176
-1%
32 883
-1%
32 773
0%
32 828
+0%
33 222
+1%
Net Income
Tax Provision
(7 781)
(8 109)
(7 815)
(7 395)
(7 474)
(7 555)
(7 725)
(7 995)
(7 810)
(7 894)
(8 061)
(8 628)
(9 246)
(9 589)
(7 522)
(6 918)
(5 966)
(5 537)
(7 534)
(7 639)
(8 074)
(8 127)
(7 954)
(8 033)
(7 862)
(8 432)
(8 967)
(10 080)
(10 942)
(12 334)
(11 439)
(10 916)
(10 680)
(9 257)
(9 892)
(10 022)
(9 967)
(9 898)
(8 975)
(9 004)
(9 135)
Income from Continuing Operations
9 975
10 367
10 601
10 193
10 288
10 673
11 695
12 352
12 475
12 738
12 435
13 678
14 980
15 813
18 215
18 240
17 313
17 509
17 633
17 879
18 857
18 967
19 185
19 349
18 951
20 216
21 435
23 877
25 736
28 777
27 157
25 910
25 331
22 031
23 156
23 394
23 209
22 985
23 798
23 824
24 087
Net Income (Common)
9 975
N/A
10 366
+4%
10 600
+2%
10 193
-4%
10 286
+1%
10 671
+4%
11 694
+10%
12 350
+6%
12 474
+1%
12 738
+2%
12 435
-2%
13 679
+10%
14 981
+10%
15 812
+6%
18 215
+15%
18 239
+0%
17 313
-5%
17 510
+1%
17 633
+1%
17 880
+1%
18 857
+5%
18 966
+1%
19 185
+1%
19 349
+1%
18 951
-2%
20 217
+7%
21 435
+6%
23 876
+11%
25 736
+8%
28 777
+12%
27 156
-6%
25 909
-5%
25 329
-2%
22 030
-13%
23 155
+5%
23 393
+1%
23 209
-1%
22 983
-1%
23 797
+4%
23 824
+0%
24 085
+1%
EPS (Diluted)
498.75
N/A
518.29
+4%
530
+2%
509.65
-4%
514.29
+1%
533.54
+4%
295.31
-45%
617.5
+109%
623.7
+1%
636.9
+2%
314.02
-51%
683.95
+118%
749.05
+10%
790.6
+6%
459.98
-42%
911.95
+98%
865.65
-5%
875.5
+1%
445.29
-49%
894
+101%
952.39
+7%
478.94
-50%
484.48
+1%
488.62
+1%
478.57
-2%
510.54
+7%
541.3
+6%
602.94
+11%
649.91
+8%
726.71
+12%
685.77
-6%
654.28
-5%
639.64
-2%
556.33
-13%
584.74
+5%
590.75
+1%
586.1
-1%
580.4
-1%
600.95
+4%
601.63
+0%
607.85
+1%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.